Natural Product Research · 2019 · 13 citations · 10 references
PharmacyMedicinal ChemistryOncologyCancer PharmacologyDrug DesignDrug DiscoveryCytotoxic ChemotherapyHeterocyclic ChemistryLead Compound DesignStructure-activity Relationship AnalysisAnticancer ActivityAnticancer ChemotherapyAnticancer Compound ScreeningChemical Structure-activity RelationshipsCytotoxicity AssaysHeterocyclic Medicinal ChemistryMedicinal Chemistry Applications
A series of usnic acid benzylidene derivatives (groups I-V) were designed, synthesized and evaluated for their anticancer activity in the search for potentially new anticancer agents. Compounds 1a, 5b, 2b, 2e and 2f exhibited the most potent cytotoxcity against K562 cell line with IC50 values of 10.0 ± 3.6, 5.6 ± 0.4, 8.8 ± 1.0, 4.5 ± 0.1 and 8.4 ± 0.4 μM, respectively. It is noteworthy that compound 2e displayed potent cytotoxicity against K562 cells without any cytotoxic effect on HEK293 normal cell line.
10
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Ayşe Tansu Koparal, Berrin Ayaz Tüylü, H. O. Türk · Natural Product Research · 2006 · 78 citations